Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) independent director
Prior approval opinions on matters related to the 15th meeting of the 8th board of directors, as independent directors of Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) (hereinafter referred to as “the company”), in accordance with the guiding opinions on the establishment of independent director system in listed companies, the governance standards of listed companies, the stock listing rules of Shenzhen Stock Exchange, the administrative measures for major asset restructuring of listed companies, the Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) articles of association and other relevant provisions, Fully reviewed the relevant matters to be submitted to the 15th meeting of the 8th board of directors for deliberation, and carefully reviewed the relevant documents. Based on our independent judgment, we hereby give the following prior approval opinions on matters related to this transaction:
1、 Matters concerning financial assistance to holding subsidiaries and their subsidiaries
The financial assistance provided by the company to the holding subsidiary and its subsidiaries is carried out without affecting its normal operation, which helps to ensure the capital demand for the business development of the holding subsidiary and its subsidiaries, helps to reduce the overall financing cost of the company, and does not damage the interests of the company and all shareholders, especially small and medium-sized shareholders. Therefore, we agree that the company will provide financial assistance to its holding subsidiaries and their subsidiaries, and agree to submit the matter to the board of directors for deliberation.
2、 Matters concerning the renewal of the company’s audit institution in 2022
With regard to the proposal of the board of directors to renew the appointment of Dahua Certified Public Accountants (special general partnership) as the company’s audit institution in 2022, we believe that Dahua Certified Public Accountants (special general partnership) strictly followed the independent audit standards for Chinese certified public accountants and expressed independent audit opinions in a diligent, fair and reasonable manner. In order to ensure the smooth progress of the company’s audit work, we agree to continue to employ Dahua Certified Public Accountants (special general partnership) as the company’s audit institution in 2022 and agree to submit it to the board of directors for deliberation.
(no text below)
(there is no text on this page, which is the signature page of Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) independent directors’ prior approval opinions on matters related to the 15th meeting of the 8th board of directors) independent directors:
Li Yongquan, Cao Yue, Zhou Yuejiang
April 13, 2022
